Eight-Year OHRP Review Ends With Determination Letter; Investigator Gets FDA Warning Letter

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Eight-Year OHRP Review Ends With Determination Letter; Investigator Gets FDA Warning Letter

J.W. Schomisch

April 29, 2022 at 11:18 AM EST

New York University (NYU) Grossman School of Medicine received a clean bill of health from the U.S. Department of Health and Human Services’ Office for Human Research Protections (OHRP) in a Determination Letter that closed out an investigation that started in 2014. “OHRP has determined that the corrective actions implemented by NYU adequately address the concerns,” the March... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Eight-Year OHRP Review Ends With Determination Letter; Investigator Gets FDA Warning Letter

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT